Revolution Medicines Inc
NASDAQ:RVMD

Watchlist Manager
Revolution Medicines Inc Logo
Revolution Medicines Inc
NASDAQ:RVMD
Watchlist
Price: 53.675 USD 6.29% Market Closed
Market Cap: 9B USD
Have any thoughts about
Revolution Medicines Inc?
Write Note

Revolution Medicines Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Revolution Medicines Inc
Stock-Based Compensation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Revolution Medicines Inc
NASDAQ:RVMD
Stock-Based Compensation
$61.8m
CAGR 3-Years
91%
CAGR 5-Years
136%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Revolution Medicines Inc's Stock-Based Compensation?
Stock-Based Compensation
61.8m USD

Based on the financial report for Dec 31, 2023, Revolution Medicines Inc's Stock-Based Compensation amounts to 61.8m USD.

What is Revolution Medicines Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
136%

Over the last year, the Stock-Based Compensation growth was 98%. The average annual Stock-Based Compensation growth rates for Revolution Medicines Inc have been 91% over the past three years , 136% over the past five years .

Back to Top